Dr Reddy's shares up 1.3% on USFDA nod for migraine drug 0 07.05.2020 08:32 Thehindubusinessline.com The shares of Dr Reddy's Laboratories gained 1.30 per cent to Rs 3,902 on Thursday. Earlier, the company had announced receiving approval nod from the Moscow.media Частные объявления сегодня Rss.plus Все новости за 24 часа